In conclusion, our findings highlight MDM4 as a critical regulator of ferroptosis in p53-mutant colon cancer, offering insights into potential therapeutic strategies targeting MDM4 and ferroptosis pathways to improve outcomes for patients with this challenging disease. The gene discussed is TP53; the disease is malignant colon neoplasm.